StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report released on Sunday. The brokerage issued a sell rating on the stock.
Ayala Pharmaceuticals Price Performance
Shares of NASDAQ:ADXS opened at $0.02 on Friday. The company has a market cap of $852,600.00, a price-to-earnings ratio of 0.00 and a beta of 1.51. The firm has a 50 day simple moving average of $0.06 and a 200 day simple moving average of $0.33. Ayala Pharmaceuticals has a one year low of $0.00 and a one year high of $1.49.
Ayala Pharmaceuticals Company Profile
See Also
- Five stocks we like better than Ayala Pharmaceuticals
- How to Calculate Return on Investment (ROI)
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- How Can Investors Benefit From After-Hours Trading
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- What are earnings reports?
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.